To mark this year’s International Day of Women and Girls in Science, Optimum is celebrating the remarkable women across our network by asking them: ‘If you could collaborate with any scientist (past or present) who would it be, and why?’ Their answers were as inspiring as they were diverse, from trailblazing pioneers to modern innovators, […]
Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has secured European Union Medical Device Regulation (MDR) certification for its STIMULAN® products. The approval confirms that STIMULAN® can be mixed with […]
Biocomposites launches SYNICEM™ spacers in Canada Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has launched its SYNICEM™ hip, knee and shoulder preformed spacers in Canada. It follows the launch of the same products in the US last October. Biocomposites, […]
As Spring 2026 fast approaches, the life sciences calendar is shaping up to be one of the most energising and opportunity-rich seasons yet. Whether you’re seeking investment, scouting innovation, or expanding your network across Europe’s most dynamic biotech hubs, these conferences promise invaluable insights and connections. With exclusive discounts, early-bird rates, and backtoback event weeks designed to maximise your time […]
Infinitopes expands seed financing to $35 million to accelerate clinical development of precision cancer vaccine Infinitopes, a clinical-stage cancer vaccine biotechnology company, announced the successful completion of the second close of its seed financing round, securing an additional $15.4 million and bringing the total raised to $35.1 million. This latest investment was co-led by Octopus […]
